naftopidil and Dysuria

naftopidil has been researched along with Dysuria in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Oh-oka, H	1

Other Studies

1 other study(ies) available for naftopidil and Dysuria

Article	Year
Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg. Urologia internationalis, 2009, Volume: 82, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Compliance; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysuria; Humans; Male; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics	2009

Article

Year

Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.

Urologia internationalis, 2009, Volume: 82, Issue:2

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Compliance; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysuria; Humans; Male; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics

2009